KRYSTAL BIOTECH, INC. Common Stock (par value $0.00001 per share) SALES AGREEMENTSales Agreement • December 31st, 2020 • Krystal Biotech, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 31st, 2020 Company Industry JurisdictionKrystal Biotech, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: